AstraZeneca’s vaccine, dumped by the West, helps fill the gaping need in the rest of the world

LONDON— AstraZeneca AZN -0.76% PLC’s Covid-19 vaccine is not authorized in the US, and governments in Canada, Australia and across Western Europe have shunned it after manufacturing problems and rare but sometimes deadly side effects. In much of the rest of the world, however, it is a crucial workhorse vaccine, reaching more people in low- … Read more

Research shows that two Pfizer vaccine doses offer less protection against Omicron than against Delta

The first major real-world study of how vaccines hold up against Omicron found that two injections from Pfizer Inc. and BioNTech SE’s Covid-19 vaccine reduced the risk of hospitalization by 70% for patients infected with the highly mutated variant. The study, by South Africa’s largest private health insurer, Discovery Ltd., found that while Omicron reduced … Read more

Eli Lilly and Foghorn team up. Foghorn stock rose.

Font size Bogdan Hoda / Dreamstime Shares of Foghorn Therapeutics rose sharply on Monday after the biotech company announced a partnership with… Eli Lilly to make oncology drugs. Shares of Foghorn (ticker: FHTX) rose 55% to $18.58. Eli Lilly (LLY) closed 1.8% higher to $248.53. Lilly will pay $300 million in cash up front for … Read more